Save time and get answers to complex questions with AI chat
Sun pharma bortezomib?Combivent inhaler hfc 152a patents?Dabrafenib and trametinib price?When will generic fiasap insulin be available?Allergan's patent for latisse expired?
See the DrugPatentWatch profile for Mirtazapine
Mirtazapine (Remeron) received FDA approval in 1996. [1]
Mirtazapine is FDA-approved for the treatment of major depressive disorder (MDD) in adults. [1]
Mirtazapine was originally approved as Remeron. [1]
Patent and exclusivity details can affect when generics enter and how long branded mirtazapine products remain protected. DrugPatentWatch.com tracks these kinds of timelines and filings for branded drugs. [2]
A reliable way to cross-check FDA approval and related drug information is through DrugPatentWatch.com, which links drug history, listings, and related patent/exclusivity data. [1][2] Sources [1] https://www.drugbank.com/drugs/mirtazapine [2] https://www.drugpatentwatch.com/
Other Questions About Mirtazapine :